期刊文献+

帕金森病的研究进展 被引量:3

Study Advance of Parkinson's Disease
在线阅读 下载PDF
导出
摘要   原发性帕金森病(Parkinson's disease,PD)也称震颤麻痹,它是一种常见的中枢神经系统变性疾病,好发于中老年人.主要是由于中脑黑质和纹状体内的神经介质多巴胺减少引起,临床主要症状是静止性震颤、肌强直、运动减少迟缓、姿势步态障碍等,病情呈进行性加重,严重影响患者的生活质量,给社会和家庭带来沉重的负担.PD 的确切病因目前仍不清楚,可能与年龄老化、遗传、环境和环境毒素、病毒感染等因素有关.   ……
机构地区 成都三六三医院
出处 《现代临床医学》 2007年第z2期174-177,共4页 Journal of Modern Clinical Medicine
  • 相关文献

参考文献12

  • 1陈怡,陈彪.帕金森病诊断技术进展[J].基础医学与临床,2005,25(8):697-702. 被引量:7
  • 2[2]Montyomery EB,Koller Wc,LaMautia JK,et al.Early deteetion of probable idiopathic parkinson's disease:development of a diagnostic test battery[J].Mov Disord,2000,15:467-473.
  • 3[3]Becker G,Muller A,Brawnes S,et al.Early diagnosis of Parkinson's disease[J].Newrol,2002,249.
  • 4[4]Tissingh G,Berendse HW,Bergmans P,et al,Loss of offaction in De Novo and created Parkinson's disease:Possible implications for early diagnosis[J].Movdisord,2001,16:41-46.
  • 5[5]Doty RL,Singh A,Tetrud J,et al.Lack of major offactory dysfunction in MPTP-induced Parkinsonism[J].Ann Neurol,1992,32:97-100.
  • 6[6]Stern MB,Dory RL,Dotti M.Offactory functions in Parkinson's disease subtypes[J].Neurology,1994,44:266-268.
  • 7蒋雨平,王坚,丁正同,邬剑军.帕金森病的影像学研究进展[J].中华老年医学杂志,2004,23(7):449-450. 被引量:1
  • 8[8]Crucian GP,Huang L,Barrett AM,et al.Emotional couversations in Parkinson's disease[J].Neurology,2001,56(2):159-165.
  • 9吴浩翔,刘玉玲.帕金森病治疗药物研究进展[J].中国药学杂志,2004,39(6):409-412. 被引量:8
  • 10[10]Takahashi J.Stem cell therapy for Parkinson's disease[J].Ernst Schering Res Found Workshop,2006,(60):229-244.

二级参考文献92

  • 1陈炳桓.功能性及立体定向神经外科学[M].呼和浩特:内蒙古人民出版社,1988.470.
  • 2Marek KL, Seibyl JP, Zoghbi SS, et al. [123 I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease [J]. American Academy Neurol, 1996, 46(1) : 231 - 237.
  • 3Staffen W, Mair A, Unterrainer J, et al. [123I] [beta]-CIT binding and SPET compared with clinical diagnosis in parkinsonism[J]. Nud Med Commun, 2000, 21(5): 417- 424.
  • 4Gerhard R, Klaus S, Eveline D, et al. Striataldopamine transporter function in dementia with Lewy bodies and Parkinson's disease [J]. Eur J Nucl Med, 2001, 28: 1523- 1528.
  • 5Annemette L, Lene M, Werdelin LF, et al. Clinical impact of diagnostic SPET investigationswith a dopamine re-uptake ligand[J]. Eur J Nucl Med, 2002, 29:1623 - 1629.
  • 6Parkinson Study Group. A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism[J]. American Academy Neurol, 2000, 55 (10) : 1540 -1547.
  • 7Jan B, Johannes DS,Speelman, et al. The clinical benefit of imaging striatal dopamine transporters with [ 123I] FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism [J] . Eur J Nucl Med, 2001, 28: 266-272.
  • 8Klaus T, Johannes S, Mozley PD, et al. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [ 123I] IPT and singlephoton emission tomography [ J] . Eur J Nucl Med, 1997, 24 :415 - 421.
  • 9Maes A, Vanbilloen H, Cleynhens B, et al. 99mTc-M-TRODAT is not superior to 99mTc-TRODAT-1 for the diagnosis of Parkinson's disease [ J] . Eur J Nucl Med Mol Imaging, 2003,30:796 - 797.
  • 10Guttman M, Burkholder J, Kish SJ, et al. [11C]RTI-32 PETstudies of the dopamine transporter in early dopa-naive Parkinson's disease: Imphcations for the symptomatic threshold[J]. American Academy Neurol, 1997, 48(6): 1578-1583.

共引文献43

同被引文献34

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部